Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Added on Methylphenidate for Youths with ADHD and DMDD
NCT03358277Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Nov 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of aripiprazole in disruptive mood dysregulation disorder (DMDD), sponsored by Tri-Service General Hospital. Primary endpoint: Child Behavior Checklist at 6 weeks. Started Nov 2014; status: completed.
02
Drugs
aripiprazole
03
Conditions
disruptive mood dysregulation disorder (DMDD)
Beyond the preview
Go deeper on NCT03358277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03358277.